|
|
Home
Search
Study Topics
Glossary
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| Sponsored by: |
United States Army Institute of Surgical Research |
|---|---|
| Information provided by: | United States Army Institute of Surgical Research |
| ClinicalTrials.gov Identifier: | NCT00517166 |
Purpose
Data will be collected on the type of tourniquet and circumstances of its use. Patients with penetrating extremity injury will have clinical and pre-clinical hospital data collected.
| Condition | Intervention |
|---|---|
|
Vascular Injury |
Device: CAT (Combat Arms Tourniquet) |
| Study Type: | Observational |
| Study Design: | Case-Only, Retrospective |
| Official Title: | Survey of Tourniquet Use in a Combat Support Hospital |
| Enrollment: | 584 |
| Study Start Date: | August 2006 |
| Study Completion Date: | March 2008 |
| Groups/Cohorts | Assigned Interventions |
|---|---|
|
A
Individuals on whom tourniquet was used.
|
Device: CAT (Combat Arms Tourniquet)
device
|
This is a performance improvement project that is a prospective observational cohort design with subgroup analyses. This project meets the criteria of research with its intent to publish. No data is generated and only existing data are used. No interventions are made and the comparisons will be with within subgroups in the cohort.
Aim 1. Describe the number of tourniquets which were appropriately used (wound required a tourniquet and tourniquet was placed properly) as assessed by treating physician
Aim 2 &3. Describe if limbs wounds with tourniquets were bleeding upon admission, resuscitation, and following tourniquet removal
Aim 4. Describe if mortality for the cohort of patients with tourniquets is different than the mortality predicted by various injury scoring systems
Aim 5. Compare patient outcomes between those in which a tourniquet was indicated but not used and those for whom a tourniquet was indicated and used
Aim 6. Determine if patients that received tourniquets for an extended time period exhibit any known tourniquet complications
Eligibility| Ages Eligible for Study: | 18 Years to 65 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
Combat soldiers on whom tourniquet was applied.
Inclusion Criteria:
Exclusion Criteria:
Contacts and Locations| Iraq | |
| Combat Support Hospital | |
| Baghdad, Iraq | |
| Principal Investigator: | John F Kragh, MD | US Army Institute of Surgical Research |
More Information
| Responsible Party: | USAISR ( John Kragh, COL, MC ) |
| Study ID Numbers: | IRAQ 06-010, I.2006.175dt |
| Study First Received: | August 14, 2007 |
| Last Updated: | July 31, 2008 |
| ClinicalTrials.gov Identifier: | NCT00517166 |
| Health Authority: | United States: Federal Government |
|
tourniquet extremity injury hemostatic device |
